Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer

NCT00002998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cisplatin
DRUG: gemcitabine hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]